Литература

1. McLaughlin V.V., Archer S.L., Badesch D.B. et al.; ACCF/AHA. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association. Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association // Circulation. – 2009. – Vol. 119 (16). – P. 22502294; J. Am. Coll. Cardiol. – 2009. – Vol. 53 (17). – P. 1573-1619.

2. Galie N., Hoeper M.M., Humbert M. et al.; ESC Committee for Practice Guidelines. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) // Eur. Heart J. – 2009, Aug 27; Eur. Respir. J. – 2009, Sep 12.

3. Galie N., Beghetti M., Gatzoulis M.A. et al. Bosentan therapy in patients with Eisenmenger syndrome: a multi-center, double-blind, randomized, placebo-controlled study // Circulation. – 2006. – Vol. 114. – P. 48-54.

4. Dimopoulos K., Inuzuka R., Goletto S. et al. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension // Circulation. – 2010. – Vol. 121. – P. 20-25.

5. Singh T.P., Rohit M., Grover A. et al. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension // Am. Heart J. – 2006. – Vol. 151. – P. 851.e1-851.e5.

6. Mukhopadhyay S., Sharma M., Ramakrishnan S. et al. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome:a preliminary observational study // Circulation. – 2006. – Vol. 114. – P. 1807-1810.

7. Fernandes S.M., Newburger J.W., Lang P. et al. Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology // Am. J. Cardiol. – 2003. – Vol. 91. – P. 632-635.

8. Rosenzweig E.B., Kerstein D., Barst R.J. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects // Circulation. – 1999. – Vol. 99. – P. 1858-1865.

9. Simonneau G., Barst R.J., Galie N. et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial // Am. J. Respir. Crit. Care Med. – 2002. – Vol. 165. – P. 800-804.